A July WebMD article titled “Antimicrobial Resistance Threat Continues During COVID” highlighted commentary from Vance Fowler, MD, and Tori Kinamon , MD Candidate at the Duke University School of Medicine, and recipient of the FDA Antibacterial Drug Resistance (DOOR) Fellowship. The input came from an online media briefing sponsored by the Infectious Diseases Society of America (IDSA) the previous day and formed the foundation of the article’s content.
The article underscores the urgency of antimicrobial resistance (AMR) and the potential complications from COVID-19 treatments. Dr. Fowler and Kinamon provide insight on these topics as well as information on the critical importance of new research and the work happening now on innovative strategies.